-
Types
CTN+
This guideline updates the 2017 guideline on clinical indications and drug regimens for PrEP and PEP in Canada and contains 31 recommendations and 10 good practice statements.
-
Types
CTN+
Find out more about what we learned and what we shared at the 20th Conference of the European AIDS Clinical Society (October 15–18, 2025)
-
Resource CategoriesTypes
Cochrane Evidence Synthesis & Methods
-
Types
Public Health Agency of Canada
This study aimed to provide the first national estimates of HBV prevalence and unawareness, and to update estimates of HCV incidence, prevalence, and unawareness in the general population and key populations in Canada for 2021. Progress towards elimination targets for 2025, namely incidence, awareness, mortality, and HBV vaccination, was also assessed
-
Resource CategoriesTypes
Treatment Access Group (TAG)
Welcome to the 2025 Pipeline Report. TAG’s annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
-
Types
GetCheckedOnline Team (BCCDC)
-
Resource CategoriesTypes
Government of Canada
This data blog presents information about stigma and discrimination in people who inject drugs in Canada (Phase 5 Tracks survey, 2024)
-
Resource CategoriesTypes
CATIE